These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 12595912

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. CRH-sub-1 receptor antagonists for the treatment of depression and anxiety.
    Ising M, Holsboer F.
    Exp Clin Psychopharmacol; 2007 Dec; 15(6):519-28. PubMed ID: 18179304
    [Abstract] [Full Text] [Related]

  • 3. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates.
    Habib KE, Weld KP, Rice KC, Pushkas J, Champoux M, Listwak S, Webster EL, Atkinson AJ, Schulkin J, Contoreggi C, Chrousos GP, McCann SM, Suomi SJ, Higley JD, Gold PW.
    Proc Natl Acad Sci U S A; 2000 May 23; 97(11):6079-84. PubMed ID: 10823952
    [Abstract] [Full Text] [Related]

  • 4. Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala.
    Bakshi VP, Smith-Roe S, Newman SM, Grigoriadis DE, Kalin NH.
    J Neurosci; 2002 Apr 01; 22(7):2926-35. PubMed ID: 11923457
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The CRH1 antagonist CP154,526 failed to alter ischemia-induced neurodegeneration and spatial memory deficits in rats but inhibited behavioral activity in the novel open field.
    Plamondon H, Khan S.
    Behav Brain Res; 2006 Jan 06; 166(1):85-92. PubMed ID: 16183143
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety.
    Holsboer F.
    J Psychiatr Res; 1999 Jan 06; 33(3):181-214. PubMed ID: 10367986
    [Abstract] [Full Text] [Related]

  • 14. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat.
    Arborelius L, Skelton KH, Thrivikraman KV, Plotsky PM, Schulz DW, Owens MJ.
    J Pharmacol Exp Ther; 2000 Aug 06; 294(2):588-97. PubMed ID: 10900236
    [Abstract] [Full Text] [Related]

  • 15. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated.
    Zobel AW, Nickel T, Künzel HE, Ackl N, Sonntag A, Ising M, Holsboer F.
    J Psychiatr Res; 2000 Aug 06; 34(3):171-81. PubMed ID: 10867111
    [Abstract] [Full Text] [Related]

  • 16. Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat.
    Zorrilla EP, Valdez GR, Nozulak J, Koob GF, Markou A.
    Brain Res; 2002 Oct 18; 952(2):188-99. PubMed ID: 12376179
    [Abstract] [Full Text] [Related]

  • 17. Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function.
    Willenberg HS, Bornstein SR, Hiroi N, Päth G, Goretzki PE, Scherbaum WA, Chrousos GP.
    Mol Psychiatry; 2000 Mar 18; 5(2):137-41. PubMed ID: 10822340
    [Abstract] [Full Text] [Related]

  • 18. Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists.
    Holsboer F, Ising M.
    Eur J Pharmacol; 2008 Apr 07; 583(2-3):350-7. PubMed ID: 18272149
    [Abstract] [Full Text] [Related]

  • 19. Corticotropin-releasing hormone antagonists, astressin B and antalarmin: differing profiles of activity in rhesus monkeys.
    Broadbear JH, Winger G, Rivier JE, Rice KC, Woods JH.
    Neuropsychopharmacology; 2004 Jun 07; 29(6):1112-21. PubMed ID: 14997174
    [Abstract] [Full Text] [Related]

  • 20. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress.
    Deak T, Nguyen KT, Ehrlich AL, Watkins LR, Spencer RL, Maier SF, Licinio J, Wong ML, Chrousos GP, Webster E, Gold PW.
    Endocrinology; 1999 Jan 07; 140(1):79-86. PubMed ID: 9886810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.